In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Encompass Health (EHC – Research Report), with a ...

A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits ...

For years PBMs have been assailed by pharma companies and Congress, and the new Trump administration looks likely to keep up the barrage.

As prescription drug prices continue to spiral and federal efforts to control them stall, state lawmakers are focusing on ...

Adjusted EPS of $1.19 decreased from $2.12 in the prior year, beating the consensus of $0.93, primarily due to a decline in ...

Truist Financial analyst David S Macdonald reiterated a Buy rating on CVS Health (CVS – Research Report) today and set a price target of ...

A bill that would subject pharmacy benefit managers to licensing by the state Department of Insurance faces a hurdle: Gov.

CVS is trying to turn around its drugstore chain and insurance business. The company spent a smaller percentage of premium ...

CVS appears uniquely positioned to improve health outcomes, and we appreciate management's focus on better leveraging its assets through digital and other means to bring a more consumer-centric ...

Humana's 2024 earnings reveal revenue growth but major structural issues impacting profitability. Learn about risks, new ...

CVS Health steered through rising costs in its insurance division to handily beat profit expectations on Wall Street. The drugstore chain and pharmacy benefits manager earned $1.64 billion, or ...

CVS Health posted Q4 sales of $97.71B, with a 23.3% rise in Health Care Benefits revenue. Fiscal 2025 adjusted EPS guidance ...